Ratios Uncovered: Breaking Down Niagen Bioscience Inc (NAGE)’s Trailing Twelve Months Metrics

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

The price of Niagen Bioscience Inc (NASDAQ: NAGE) closed at $8.45 in the last session, down -3.21% from day before closing price of $8.73. In other words, the price has decreased by -$3.21 from its previous closing price. On the day, 1.32 million shares were traded.

Ratios:

We take a closer look at NAGE’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 55.26. For the most recent quarter (mrq), Quick Ratio is recorded 3.06 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.04.

On August 11, 2022, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $6 to $2.40.

On March 08, 2022, ROTH Capital started tracking the stock assigning a Buy rating and target price of $7.ROTH Capital initiated its Buy rating on March 08, 2022, with a $7 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Lopez Carlos Luis bought 273 shares for $7.86 per share. The transaction valued at 2,146 led to the insider holds 2,251 shares of the business.

Jaksch Frank L Jr sold 37,161 shares of NAGE for $229,956 on Dec 13 ’24. The Director now owns 244,179 shares after completing the transaction at $6.19 per share. On Dec 13 ’24, another insider, Frank Jaksch Jr., who serves as the affiliate of the company, bought 37,161 shares for $6.19 each.

Valuation Measures:

As of this moment, Niagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 80.25, and their Forward P/E ratio for the next fiscal year is 38.41. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.60 while its Price-to-Book (P/B) ratio in mrq is 14.18.

Stock Price History:

Over the past 52 weeks, NAGE has reached a high of $9.18, while it has fallen to a 52-week low of $2.31. The 50-Day Moving Average of the stock is 19.13%, while the 200-Day Moving Average is calculated to be 57.67%.

Shares Statistics:

A total of 77.33M shares are outstanding, with a floating share count of 49.16M. Insiders hold about 36.77% of the company’s shares, while institutions hold 29.53% stake in the company.

Most Popular